Organon & Co. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
OGN New York 2830 www.organon.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Organon & Co.

Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It - Oct 26th, 2026 6:00 am
Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing - Oct 19th, 2026 5:30 am
Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting - Oct 16th, 2026 5:30 am
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know - Oct 14th, 2026 6:00 am
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock - Oct 2nd, 2026 6:00 am
Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference - Oct 1st, 2026 6:00 am
Organon Canada announces the Approval and Availability of NDUVRA® (tapinarof cream), 1%, a New Steroid-Free Topical Treatment for Moderate to Severe Atopic Dermatitis in Adult and Pediatric Patients 2 Years of Age and Older - Sep 28th, 2026 6:01 am
Why Organon (OGN) Is Getting Attention Today - Sep 22nd, 2026 6:15 am
Organon (OGN) Wins FDA Review Acceptance For Its Hormone Free Contraceptive Device - Sep 21st, 2026 9:24 pm
Is Trending Stock Organon & Co. (OGN) a Buy Now? - Sep 21st, 2026 7:00 am
PhaseV Appoints Biopharma Leaders Klaus Beck and Avi Kulkarni to Scientific Advisory Board to Guide Expansion of AI Conductor - Sep 16th, 2026 6:30 am
Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device - Sep 14th, 2026 5:30 am
The Surprising Pockmarks On Cooper's Earnings That Caused Its Stock To Dive - Sep 10th, 2026 2:18 pm
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Sep 8th, 2026 7:00 am
Orogen Royalties Acquires Two Gold Projects in Southwest Utah - Sep 2nd, 2026 6:00 am
Arletta Pharma Solutions Appoints Jeannette Jager-van Dijk as Chief Executive Officer - Sep 1st, 2026 5:18 am
National Can-RISE Study to Help Close Critical Gaps in Menopause Research - Aug 27th, 2026 7:00 am
Orogen Royalties Announces Results of the 2026 Annual General Meeting - Aug 13th, 2026 5:30 pm
Priori Expands Client Advisory Board with New Members from Fortune 500 Corporate Legal Departments - Aug 13th, 2026 7:00 am
Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability - Aug 11th, 2026 5:30 am